Norges Bank Purchases Shares of 1,939,322 Option Care Health, Inc. $OPCH

Norges Bank purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, Holdings Channel reports. The firm purchased 1,939,322 shares of the company’s stock, valued at approximately $61,787,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health in the 4th quarter valued at about $25,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health in the 3rd quarter valued at about $35,000. McIlrath & Eck LLC acquired a new position in shares of Option Care Health in the 2nd quarter valued at about $37,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health during the 3rd quarter valued at about $38,000. Finally, Hantz Financial Services Inc. raised its holdings in shares of Option Care Health by 987.7% during the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after buying an additional 1,284 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan bought 24,154 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The stock was purchased at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the purchase, the director directly owned 73,383 shares in the company, valued at $1,518,294.27. This trade represents a 49.06% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John Charles Rademacher bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the purchase, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 73,264 shares of company stock worth $1,548,316 in the last 90 days. 1.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. TD Cowen dropped their price objective on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Weiss Ratings downgraded Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Morgan Stanley set a $28.00 price objective on Option Care Health in a report on Wednesday, May 6th. Truist Financial set a $30.00 price target on Option Care Health in a report on Friday, May 1st. Finally, Stephens set a $30.00 price target on Option Care Health in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $31.25.

Option Care Health Stock Performance

OPCH opened at $20.51 on Monday. The company has a market cap of $3.22 billion, a PE ratio of 15.90, a price-to-earnings-growth ratio of 1.14 and a beta of 0.67. The stock has a 50-day moving average of $24.32 and a 200-day moving average of $29.54. Option Care Health, Inc. has a 52-week low of $18.01 and a 52-week high of $36.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter in the prior year, the company posted $0.40 EPS. The firm’s revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities research analysts forecast that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.